ADAR and cancer: In this study, we identified that targeting LNC-SNO49AB decreases the global A-to-I RNA-editing rate by impairing ADAR1 dimerization, revealing a previously unrecognized strategy by which lncRNAs regulate the global epitranscriptome in cancer.